Shirai T, Yamamoto A, Imaida K, Tamano S, Mori T, Hasegawa R
First Department of Pathology, Nagoya City University Medical School, Japan.
Teratog Carcinog Mutagen. 1992;12(2):71-7. doi: 10.1002/tcm.1770120204.
The present experiment was undertaken to investigate possible synergism in induction of rat prostate tumor. F344 rats were repeatedly administered the prostate carcinogens 3,2'-dimethyl-4-aminobiphenyl (DMAB),N-nitrosobis(2-oxopropyl)amine(BOP), and N-methylnitrosourea (MNU) sequentially or together at times of hormonal castration induced regenerative cell proliferation of prostate epithelial cells. Group 1 animals received two 100 mg/kg doses of DMAB, two 20 mg/kg applications of BOP, and two times 15 mg/kg of MNU. Groups 2, 3, and 4, respectively, received each of the carcinogen treatment alone. Group 5 was given 6 applications of all three in combination, each at one-third the dose administered to the other groups. The results showed a clear synergism in enhanced tumor development in the colon but not in the prostate, in which the incidence of lesions induced by the three carcinogens was similar to that with DMAB alone.
本实验旨在研究诱导大鼠前列腺肿瘤时可能存在的协同作用。在激素去势诱导前列腺上皮细胞再生性细胞增殖时,对F344大鼠依次或同时反复给予前列腺致癌物3,2'-二甲基-4-氨基联苯(DMAB)、N-亚硝基双(2-氧代丙基)胺(BOP)和N-甲基亚硝基脲(MNU)。第1组动物接受两次100 mg/kg剂量的DMAB、两次20 mg/kg剂量的BOP和两次15 mg/kg剂量的MNU。第2、3和4组分别单独接受每种致癌物处理。第5组联合给予所有三种致癌物6次,每次剂量为其他组给药剂量的三分之一。结果显示,在增强结肠肿瘤发展方面存在明显的协同作用,但在前列腺中未观察到,三种致癌物诱导的病变发生率与单独使用DMAB时相似。